Inquire Before Buying - EZH2 Inhibitors Market Size, Share, Growth

Global EZH2 Inhibitors Market Research Report: Forecast (2024-2030)

Global EZH2 Inhibitors Market Report - By Type of Therapy (Monotherapy, Combination Therapy), By Application (Epithelioid Sarcoma, Non-Hodgkin's Lymphoma, Prostate Cancer, Breast C......ancer, Lung Cancer, Others), By End Users (Hospitals & Research Institutes, Speciality Clinics), By Region (North America, South America, Europe, The Middle East & Africa, Asia-Pacific), By Company (Daichi Sankyo Co. Ltd., Epizyme Inc., Merck KGaA, Pfizer Inc., Eternity Bioscience, Kainos Medicine, Morphosys AG, Jiangsu Hengrui Pharmaceuticals Co. Ltd, Others) Read more

Healthcare
Jul 2024
Pages 193
Report Format: PDF, Excel, PPT

Market Definition

EZH2 (Enhancer of the Zeste Homolog 2) gene is responsible for the production of histone methyltransferase enzymes, which causes the methylation of histones and subsequent suppression of downstream genes. This suppression activity forms a crucial part of cell fate determination. The EZH2 gene has been validated across various studies to suppress the growth of cancer cells.

Market Insights & Analysis: Global EZH2 Inhibitors Market (2024-30):

The Global EZH2 Inhibitors Market is projected to grow at a CAGR of around 25.85% during the forecast period, i.e., 2024-30. It owes to increasing R&D investments by biotechnology companies and government institutions in developing new therapies to address the escalating number of cancer patients worldwide. EZH2 inhibitors are regarded as promising cancer treatment drugs, which is a result of ongoing clinical trials and research to explore their potential as a novel target therapy for cancer treatment. Hence, with a rise in healthcare spending for cancer & related treatments, EZH2 inhibitors are anticipated to witness high demand in the coming years.

According to the National Health Expenditure data, the US healthcare spending grew 2.7% to around USD 4.3 Trillion in 2021, or USD 12,914 per person, and accounted for 18.3% of the Gross Domestic Product (GDP).

Report Coverage	Details
Study Period	Historical Data: 2019-22
	Base Year: 2023
	Forecast Period: 2024-30
CAGR (2024-2030)	25.85%
Regions Covered	North America: US, Canada
	Europe: Germany, The UK, France, Rest of Europe
	Asia-Pacific: China, Japan, Rest of Asia-Pacific
	South America: Brazil, Rest of South America
	Middle East and Africa
Key Companies Profiled	Daichi Sankyo Co. Ltd., Epizyme Inc., Merck KGaA, Pfizer Inc., Eternity Bioscience, Kainos Medicine, Morphosys AG, Jiangsu Hengrui Pharmaceuticals Co. Ltd, Others
Unit Denominations	USD Million/Billion

With the advent of next-generation sequencing, many molecular alterations & sequences of cancer have been identified. These alterations of DNA methylation and histone modification have led to the protein that can change the structure of DNA and other molecules, which can affect gene expressions. These changes in gene structure help in the development of cancer progression drugs and, in turn, positively impact market growth. Moreover, the implication of EZH2 drugs in various malignant tumors like prostate, breast, & pancreas, among others, is anticipated to increase its use among cancer-diagnosed patients.

Apart from this, the increasing acceptance & approval of these drugs in various geographies like Japan, China, etc., and the continuous development of these drugs for advanced alteration, would further aid the growth of the Global EZH2 Inhibitors Market in the forecast years.

Global EZH2 Inhibitors Market Driver:

Globally Rising Number of Cancer Patients: Globally, the cancer patient population has been growing at a rapid pace, backed by the rise in cancer-causing chemicals in the environment and the increased penetration of natural UV radiation. Consequently, there's a surging need for accurate & convenient diagnostic systems for the early detection of cancer, i.e., instigating the demand for developing EZH2 inhibitors, which have a favorable safety profile and a promising immunogenic potential. EZH2 inhibitors hold the potential to enhance the efficacy of cancer treatment, especially for patients with lung & prostate cancer, in which specific target drugs are used. Hence, increased investments by governments & pharmaceutical companies in R&D for new cancer treatments are anticipated to drive the Global EZH2 Inhibitors Market in the coming years.

Global EZH2 Inhibitors Market Research Report (2024-2030) - Table of Contents

Market Segmentation
Introduction
1. Product Definition
2. Research Process
3. Assumptions
Executive Summary
Global EZH2 Inhibitors Market Drug Pipeline Analysis
1. By Drug Class
2. By Mechanism of Action
3. By Route of Administration
4. By Phase of Therapy
5. By Target Disease Indication
Global EZH2 Inhibitors Market Dynamics
1. Growth Drivers
2. Challenges
Global EZH2 Inhibitors Market Recent Development
1. Marketed
  1. By Product
  2. Regulation
2. Emerging
  1. By Product
  2. By Clinical Development
Global EZH2 Inhibitors Market Hotspots & Opportunities
Global EZH2 Inhibitors Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Type of Therapy
    1. Monotherapy
    2. Combination Therapy
  2. By Application
    1. Epithelioid Sarcoma
    2. Non-Hodgkin's Lymphoma
    3. Prostate Cancer
    4. Breast Cancer
    5. Lung Cancer
    6. Others (Ovary, Leukaemia, etc.)
  3. By End Users
    1. Hospitals & Research Institutes
    2. Speciality Clinics
  4. By Region
    1. North America
    2. South America
    3. Europe
    4. The Middle East & Africa
    5. Asia-Pacific
  5. By Company
    1. Competition Characteristics
    2. Revenue Shares & Analysis
North America EZH2 Inhibitors Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Type of Therapy
  2. By Application
  3. By End User
  4. By Country
    1. The US
    2. Canada
3. The US EZH2 Inhibitors Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type of Therapy
    2. By Application
4. Canada EZH2 Inhibitors Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type of Therapy
    2. By Application
South America EZH2 Inhibitors Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Type of Therapy
  2. By Application
  3. By End User
  4. By Country
    1. Brazil
    2. Rest of South America
3. Brazil EZH2 Inhibitors Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type of Therapy
    2. By Application
Europe EZH2 Inhibitors Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Type of Therapy
  2. By Application
  3. By End User
  4. By Country
    1. Germany
    2. The UK
    3. France
    4. Rest of Europe
3. Germany EZH2 Inhibitors Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type of Therapy
    2. By Application
4. The UK EZH2 Inhibitors Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type of Therapy
    2. By Application
5. France EZH2 Inhibitors Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type of Therapy
    2. By Application
The Middle East & Africa EZH2 Inhibitors Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Type of Therapy
  2. By Application
  3. By End User
  4. By Country
    1. The Middle East
    2. Africa
3. The Middle East EZH2 Inhibitors Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type of Therapy
    2. By Application
4. Africa EZH2 Inhibitors Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type of Therapy
    2. By Application
Asia-Pacific EZH2 Inhibitors Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Type of Therapy
  2. By Application
  3. By End User
  4. By Country
    1. China
    2. Japan
    3. Rest of Asia-Pacific
3. China EZH2 Inhibitors Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type of Therapy
    2. By Application
4. Japan EZH2 Inhibitors Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type of Therapy
    2. By Application
Global EZH2 Inhibitors Market Key Strategic Imperatives for Success & Growth
Competition Outlook
1. Competition Matrix
  1. Product Portfolio
  2. Target Markets
  3. Research & Development
  4. Strategic Alliances
  5. Strategic Initiatives
2. Company Profiles (Business Description, Product Segments, Business Segments, Financials, Strategic Alliances/ Partnerships, Future Plans)
  1. Daichi Sankyo Co. Ltd.
  2. Epizyme Inc.
  3. Merck KGaA
  4. Pfizer Inc.
  5. Eternity Bioscience
  6. Kainos Medicine
  7. Morphosys AG
  8. Jiangsu Hengrui Pharmaceuticals Co. Ltd
  9. Others
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

FILL THE FORM TO INQUIRE BEFORE BUYING THIS REPORT

Name *

Email ID *

Country *

Contact Number *

Your Enquiry Details

Your data is 100% confidential & secure

By submitting, you agree to our Terms and Privacy Policy .

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now

Related Reports

Talk to our Consultant

Customization Offered

Request Customization